Dermatophytic Onychomycosis Market to Grow 7.44% (2016-2020) - Key Vendors are Novartis, GlaxoSmithKline & Valeant Pharmaceuticals

Dublin, March 04, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/97bx43/global) has announced the addition of the "Global Dermatophytic Onychomycosis Market 2016-2020" report to their offering.

The global dermatophytic onychomycosis market is expected to grow at a CAGR of 7.44% during the period 2016-2020.

According to the report, the increase in R&D to develop drugs with disease-modifying properties and a better safety and efficacy profile drives the market.

It has been found that a combination of topical and systemic treatment increases the cure rate when compared to individual therapies. For instance, a combination of amorolfine nail lacquer and oral terbinafine, the most commonly used combination therapy, has improved clinical efficiency and is more cost-effective than terbinafine alone.

Further, the report states that the side effects associated with dermatophytic onychomycosis drugs are a challenge to the market as they hamper the acceptance of advanced drugs to treat moderate to severe dermatophytic onychomycosis.

Key vendors:

• Anacor Pharmaceuticals
• Galderma
• Janssen Biotech
• Novartis
• Valeant Pharmaceuticals
  

Key questions answered in this report:

• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Overview: Dermatophytic onychomycosis

PART 06: Pipeline analysis

PART 07: Market landscape

PART 08: Market segmentation by route of administration

PART 09: Geographical segmentation

PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape

Companies Mentioned:

• Anacor Pharmaceuticals
• Galderma
• Janssen Biotech
• Novartis
• Valeant Pharmaceuticals
• Abeona Therapeutics
• Allergan
• Elorac
• GlaxoSmithKline
• Hexima
• Hisamitsu Pharmaceutical
• Mayne Pharma
• MediQuest Therapeutics
• Meiji Seika Pharma
• Merz Pharma
• Moberg P
  

For more information visit http://www.researchandmarkets.com/research/97bx43/global

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716